Atyr Pharma Inc
NASDAQ:LIFE
| Market Cap (Intraday) | 224.54M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $8.25 |
| 50-Day MA | $8.98 |
| 200-Day MA | $5.79 |
Atyr Pharma Inc Stock, NASDAQ:LIFE
3545 John Hopkins Court, Suite 250, San Diego, California 92121
United States of America
Phone: +1.858.731.8389
Number of Employees: 43
Description
aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel immunological pathways. Its product pipeline include ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1;DARS-1(3). The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.